Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The “Oncology Treatment Drug Industry Forecast” looks at past sales and reviews total world Oncology Treatment Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Treatment Drug sales for 2023 through 2029. With Oncology Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Oncology Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Treatment Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Treatment Drug.
The global Oncology Treatment Drug market size is projected to grow from US$ 193150 million in 2022 to US$ 337490 million in 2029; it is expected to grow at a CAGR of 8.3% from 2023 to 2029.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Treatment Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Segmentation by application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Treatment Drug Market Size 2018-2029
2.1.2 Oncology Treatment Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncology Treatment Drug Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Treatment Drug Market Size by Type
2.3.1 Oncology Treatment Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncology Treatment Drug Market Size Market Share by Type (2018-2023)
2.4 Oncology Treatment Drug Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Others
2.5 Oncology Treatment Drug Market Size by Application
2.5.1 Oncology Treatment Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncology Treatment Drug Market Size Market Share by Application (2018-2023)
3 Oncology Treatment Drug Market Size by Player
3.1 Oncology Treatment Drug Market Size Market Share by Players
3.1.1 Global Oncology Treatment Drug Revenue by Players (2018-2023)
3.1.2 Global Oncology Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncology Treatment Drug by Regions
4.1 Oncology Treatment Drug Market Size by Regions (2018-2023)
4.2 Americas Oncology Treatment Drug Market Size Growth (2018-2023)
4.3 APAC Oncology Treatment Drug Market Size Growth (2018-2023)
4.4 Europe Oncology Treatment Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncology Treatment Drug Market Size Growth (2018-2023)
5 Americas
5.1 Americas Oncology Treatment Drug Market Size by Country (2018-2023)
5.2 Americas Oncology Treatment Drug Market Size by Type (2018-2023)
5.3 Americas Oncology Treatment Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Treatment Drug Market Size by Region (2018-2023)
6.2 APAC Oncology Treatment Drug Market Size by Type (2018-2023)
6.3 APAC Oncology Treatment Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncology Treatment Drug by Country (2018-2023)
7.2 Europe Oncology Treatment Drug Market Size by Type (2018-2023)
7.3 Europe Oncology Treatment Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncology Treatment Drug by Region (2018-2023)
8.2 Middle East & Africa Oncology Treatment Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncology Treatment Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oncology Treatment Drug Market Forecast
10.1 Global Oncology Treatment Drug Forecast by Regions (2024-2029)
10.1.1 Global Oncology Treatment Drug Forecast by Regions (2024-2029)
10.1.2 Americas Oncology Treatment Drug Forecast
10.1.3 APAC Oncology Treatment Drug Forecast
10.1.4 Europe Oncology Treatment Drug Forecast
10.1.5 Middle East & Africa Oncology Treatment Drug Forecast
10.2 Americas Oncology Treatment Drug Forecast by Country (2024-2029)
10.2.1 United States Oncology Treatment Drug Market Forecast
10.2.2 Canada Oncology Treatment Drug Market Forecast
10.2.3 Mexico Oncology Treatment Drug Market Forecast
10.2.4 Brazil Oncology Treatment Drug Market Forecast
10.3 APAC Oncology Treatment Drug Forecast by Region (2024-2029)
10.3.1 China Oncology Treatment Drug Market Forecast
10.3.2 Japan Oncology Treatment Drug Market Forecast
10.3.3 Korea Oncology Treatment Drug Market Forecast
10.3.4 Southeast Asia Oncology Treatment Drug Market Forecast
10.3.5 India Oncology Treatment Drug Market Forecast
10.3.6 Australia Oncology Treatment Drug Market Forecast
10.4 Europe Oncology Treatment Drug Forecast by Country (2024-2029)
10.4.1 Germany Oncology Treatment Drug Market Forecast
10.4.2 France Oncology Treatment Drug Market Forecast
10.4.3 UK Oncology Treatment Drug Market Forecast
10.4.4 Italy Oncology Treatment Drug Market Forecast
10.4.5 Russia Oncology Treatment Drug Market Forecast
10.5 Middle East & Africa Oncology Treatment Drug Forecast by Region (2024-2029)
10.5.1 Egypt Oncology Treatment Drug Market Forecast
10.5.2 South Africa Oncology Treatment Drug Market Forecast
10.5.3 Israel Oncology Treatment Drug Market Forecast
10.5.4 Turkey Oncology Treatment Drug Market Forecast
10.5.5 GCC Countries Oncology Treatment Drug Market Forecast
10.6 Global Oncology Treatment Drug Forecast by Type (2024-2029)
10.7 Global Oncology Treatment Drug Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Treatment Drug Product Offered
11.1.3 Roche Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Oncology Treatment Drug Product Offered
11.2.3 Celgene Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Oncology Treatment Drug Product Offered
11.3.3 Novartis Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Oncology Treatment Drug Product Offered
11.4.3 Bristol-Myers Squibb Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Oncology Treatment Drug Product Offered
11.5.3 Johnson & Johnson Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Information
11.6.2 Merck & Co. Oncology Treatment Drug Product Offered
11.6.3 Merck & Co. Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Merck & Co. Main Business Overview
11.6.5 Merck & Co. Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Oncology Treatment Drug Product Offered
11.7.3 AstraZeneca Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Oncology Treatment Drug Product Offered
11.8.3 Pfizer Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Oncology Treatment Drug Product Offered
11.9.3 Amgen Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Oncology Treatment Drug Product Offered
11.10.3 Eli Lilly Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 AbbVie
11.11.1 AbbVie Company Information
11.11.2 AbbVie Oncology Treatment Drug Product Offered
11.11.3 AbbVie Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AbbVie Main Business Overview
11.11.5 AbbVie Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Oncology Treatment Drug Product Offered
11.12.3 Takeda Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Astellas
11.13.1 Astellas Company Information
11.13.2 Astellas Oncology Treatment Drug Product Offered
11.13.3 Astellas Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Astellas Main Business Overview
11.13.5 Astellas Latest Developments
11.14 Ipsen
11.14.1 Ipsen Company Information
11.14.2 Ipsen Oncology Treatment Drug Product Offered
11.14.3 Ipsen Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Ipsen Main Business Overview
11.14.5 Ipsen Latest Developments
11.15 Sanofi
11.15.1 Sanofi Company Information
11.15.2 Sanofi Oncology Treatment Drug Product Offered
11.15.3 Sanofi Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sanofi Main Business Overview
11.15.5 Sanofi Latest Developments
11.16 Bayer
11.16.1 Bayer Company Information
11.16.2 Bayer Oncology Treatment Drug Product Offered
11.16.3 Bayer Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Bayer Main Business Overview
11.16.5 Bayer Latest Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Information
11.17.2 Biogen Idec Oncology Treatment Drug Product Offered
11.17.3 Biogen Idec Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Biogen Idec Main Business Overview
11.17.5 Biogen Idec Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Treatment Drug Product Offered
11.18.3 Teva Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Treatment Drug Product Offered
11.19.3 Otsuka Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Eisai
11.20.1 Eisai Company Information
11.20.2 Eisai Oncology Treatment Drug Product Offered
11.20.3 Eisai Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Eisai Main Business Overview
11.20.5 Eisai Latest Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Information
11.21.2 Merck KGaA Oncology Treatment Drug Product Offered
11.21.3 Merck KGaA Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Merck KGaA Main Business Overview
11.21.5 Merck KGaA Latest Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Information
11.22.2 Gilead Sciences Oncology Treatment Drug Product Offered
11.22.3 Gilead Sciences Oncology Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Gilead Sciences Main Business Overview
11.22.5 Gilead Sciences Latest Developments
12 Research Findings and Conclusion
*If Applicable.